We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

204 hedge funds and large institutions have $1.1B invested in Immunogen Inc in 2018 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 69 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more capital invested

Capital invested by funds: $666M → $1.1B (+$438M)

19% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 37

2% more funds holding

Funds holding: 200 → 204 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 69

68% less call options, than puts

Call options by funds: $8.85M | Put options by funds: $27.5M

Holders
204
Holders Change
+4
Holders Change %
+2%
% of All Funds
4.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
44
Increased
59
Reduced
69
Closed
37
Calls
$8.85M
Puts
$27.5M
Net Calls
-$18.6M
Net Calls Change
-$20.2M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$54.4M
2
Renaissance Technologies
Renaissance Technologies
New York
+$36.7M
3
PC
PointState Capital
New York
+$16.5M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.79M
5
Goldman Sachs
Goldman Sachs
New York
+$6.89M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$16.4M
2
ClearBridge Investments
ClearBridge Investments
New York
-$14.7M
3
O
OrbiMed
New York
-$13.1M
4
Millennium Management
Millennium Management
New York
-$12.9M
5
RG
Redmile Group
California
-$11.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
126
Element Capital Management
New York
$181K +$170K +17,221 New
USAA
127
United Services Automobile Association
Texas
$173K +$163K +16,490 New
US Bancorp
128
US Bancorp
Minnesota
$167K +$8.77K +888 +6%
GAM
129
Gould Asset Management
California
$158K – – –
Commonwealth Equity Services
130
Commonwealth Equity Services
Massachusetts
$147K -$16.7K -1,692 -11%
LCM
131
Laurion Capital Management
New York
$144K +$135K +13,700 New
AB
132
Amalgamated Bank
New York
$140K -$1.98K -200 -1%
AG
133
Advisor Group
Arizona
$139K -$5.79K -586 -4%
OAM
134
Oppenheimer Asset Management
New York
$136K -$1.45K -147 -1%
Creative Planning
135
Creative Planning
Kansas
$132K -$50.9K -5,158 -29%
JCM
136
Jacobi Capital Management
Pennsylvania
$127K -$24.7K -2,500 -17%
QSS
137
Quantitative Systematic Strategies
Florida
$126K +$118K +11,964 New
CSS
138
Cubist Systematic Strategies
Connecticut
$123K -$470K -47,544 -80%
CG
139
Caprock Group
Idaho
$120K +$112K +11,360 New
HighTower Advisors
140
HighTower Advisors
Illinois
$119K -$7.54K -763 -6%
Zurich Cantonal Bank
141
Zurich Cantonal Bank
Switzerland
$117K +$73.2K +7,411 +199%
SC
142
Scotia Capital
Ontario, Canada
$114K -$6.91K -700 -6%
ASN
143
Advisory Services Network
Georgia
$114K -$1.6K -162 -1%
FDCDDQ
144
Federation des caisses Desjardins du Quebec
Quebec, Canada
$105K – – –
TWA
145
TCI Wealth Advisors
Arizona
$105K +$59.3K +6,000 +150%
CG
146
Cutler Group
California
$98K +$74.6K +7,550 +421%
Canada Life
147
Canada Life
Manitoba, Canada
$95K – – –
LTFS
148
Ladenburg Thalmann Financial Services
Florida
$94K +$4.08K +413 +5%
QT
149
Quantbot Technologies
New York
$86K +$81.6K +8,264 New
AIP
150
Ameritas Investment Partners
Nebraska
$83K – – –
4 5
6
7 8

IMGN Hedge Fund Activity: Q1 2018 in Review

204 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2018, worth a combined $1.1B — up 66% from $666M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new IMGN positions and 37 closed out — a net gain of 7 holders — while 59 added to existing stakes and 69 trimmed.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $54.4M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $16.4M sold.

  • 204 institutional investors held Immunogen Inc (IMGN) as of Q1 2018, up from 200 in Q4 2017.
  • Funds reported $1.1B of Immunogen Inc stock for Q1 2018, up 66% quarter-over-quarter.
  • 44 funds opened new Immunogen Inc positions in Q1 2018 and 37 closed out, a net change of +7 holders.
  • The largest Immunogen Inc buyer in Q1 2018 was Capital Research Global Investors, an estimated $54.4M added.
  • The largest Immunogen Inc seller in Q1 2018 was Baker Bros. Advisors, an estimated $16.4M sold.

Based on aggregated 13F filings for Q1 2018.